Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-09
DOI
10.1038/s41467-020-15424-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to
- (2019) Renee Brady et al. BULLETIN OF MATHEMATICAL BIOLOGY
- Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- (2019) Kim N. Chi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
- (2019) Alex P. Hoyle et al. EUROPEAN UROLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
- (2018) Christos E. Kyriakopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimal Control to Develop Therapeutic Strategies for Metastatic Castrate Resistant Prostate Cancer
- (2018) Jessica J. Cunningham et al. JOURNAL OF THEORETICAL BIOLOGY
- Optimizing Cancer Treatment Using Game Theory
- (2018) Katerina Stanková et al. JAMA Oncology
- Targeting Apoptotic Activity Against Prostate Cancer Stem Cells
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
- (2016) Gwenaelle Gravis et al. EUROPEAN UROLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
- (2016) Claire L Vale et al. LANCET ONCOLOGY
- Intercellular Coupling of the Cell Cycle and Circadian Clock in Adult Stem Cell Culture
- (2016) Toru Matsu-ura et al. MOLECULAR CELL
- Mathematical Models of Androgen Resistance in Prostate Cancer Patients under Intermittent Androgen Suppression Therapy
- (2016) Javier Baez et al. Applied Sciences-Basel
- Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer
- (2015) Jeanny B. Aragon-Ching et al. Clinical Genitourinary Cancer
- Cancer stem cells: small subpopulation or evolving fraction?
- (2015) Heiko Enderling Integrative Biology
- Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data
- (2015) Moran Elishmereni et al. PROSTATE
- Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy
- (2015) Yoshito Hirata et al. PLoS One
- Mechanisms of Resistance to Intermittent Androgen Deprivation in Patients with Prostate Cancer Identified by a Novel Computational Method
- (2014) J. D. Morken et al. CANCER RESEARCH
- Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
- (2013) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate Cancer Stem Cells
- (2012) Shi-Ming Tu et al. Clinical Genitourinary Cancer
- A practical approach to parameter estimation applied to model predicting heart rate regulation
- (2012) Mette S. Olufsen et al. JOURNAL OF MATHEMATICAL BIOLOGY
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- (2012) Juanita M. Crook et al. NEW ENGLAND JOURNAL OF MEDICINE
- New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells
- (2012) Soo Ok Lee et al. Journal of Molecular Cell Biology
- A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy
- (2012) Travis Portz et al. AIP Advances
- Circadian clocks and cell division
- (2010) Carl Hirschie Johnson CELL CYCLE
- Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
- (2010) Yoshito Hirata et al. JOURNAL OF THEORETICAL BIOLOGY
- Prostate Cancer Stem Cells: A New Target for Therapy
- (2008) Norman J. Maitland et al. JOURNAL OF CLINICAL ONCOLOGY
- A Mathematical Model of Intermittent Androgen Suppression for Prostate Cancer
- (2008) Aiko Miyamura Ideta et al. JOURNAL OF NONLINEAR SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search